FDA publishes 200 complete response letters in transparency effort
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesPharmaceuticalsProduct LifecycleSubmission and registrationUnited StatesRegulatory NewsJoanne S. EglovitchApproval/marketing authorizationBiologics/ biosimilars/ vaccinesPharmaceuticalsProduct LifecycleSubmission and registrationUnited States